For more than a century, type 1 diabetes has been managed, not cured. Patients inject insulin, monitor blood sugar obsessively, and live with the constant shadow of long-term complications. But now, for the first time in history, scientists may have found a way to outsmart the immune system itself—replacing what’s broken with engineered cells that refuse to be rejected. This isn’t just medicine; it’s a glimpse into the future of cellular engineering as a tool to rewrite the rules of human health.
Continue reading… “The Beginning of the End for Type 1 Diabetes? Gene-Edited Cells Outsmart the Immune System”
